Dr. Jay Sigel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2826 Center Dr, Vernon, TX 76384 Phone: 940-552-0700 Fax: 940-552-0700 |
Mr. Robert Henry Borchardt Jr., MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1015 Hillcrest Dr, Vernon, TX 76384 Phone: 940-552-5495 Fax: 940-552-2473 |
Adanna Juliet Amechi Obigwe, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1015 Hillcrest Dr Ste A, Vernon, TX 76384 Phone: 940-552-2530 Fax: 940-552-2539 |
Dr. Francis Anwasi, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 College Dr, Suite 700, Vernon, TX 76384 Phone: 940-552-9352 |
Mr. Milton L Brownlow, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1015 Hillcrest Dr, Vernon, TX 76384 Phone: 940-552-5495 Fax: 940-552-2473 |
Dr. Travis Edward Lehman, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 College Dr, Vernon, TX 76384 Phone: 940-553-2890 Fax: 940-553-2891 |
Dr. Randall L. Schaffner, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 College Dr, Suite # 300, Vernon, TX 76384 Phone: 940-552-0552 Fax: 940-552-0559 |
News Archive
Pfizer Inc. announced today that, in the interest of patient safety, it is voluntarily withdrawing ThelinĀ® (sitaxentan) for the treatment of pulmonary arterial hypertension (PAH) in regions where it is approved (the European Union, Canada and Australia). In addition, Pfizer is discontinuing clinical studies of Thelin worldwide.
The National Institutes of Health awarded Penn State researchers a $1.85 million grant to develop a new way to test if dysfunctions in certain areas of the brain lead to mental health complications and brain disorders. If proven, the research would lead to better mental health treatments.
The aging of the U.S. population will have broad economic consequences for the country, particularly for federal programs that support the elderly, and its long-term effects on all generations will be mediated by how - and how quickly - the nation responds, says a new congressionally mandated report from the National Research Council.
Biovail Corporation today announced that the United States Food and Drug Administration (FDA) has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 145mg and 48mg strengths of fenofibrate tablets (sold under the brand name Tricor by Abbott Laboratories).
New research published in the Journal of Leukocyte Biology, shows that the development of white matter in the mouse brains is delayed when they are exposed to chronic low oxygen levels shortly after birth.
› Verified 5 days ago